NCT04066790 2020-05-19
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Terminated
Shanghai Jiao Tong University School of Medicine
Washington University School of Medicine
Vanderbilt-Ingram Cancer Center
SWOG Cancer Research Network